This subanalysis of the FAST trial, which compared methotrexate and mycophenolate mofetil in noninfectious uveitis, evaluated time to corticosteroid-sparing control of inflammation. Source: AAO
Faricimab was approved by the FDA in January 2022 for the treatment of neovascular AMD and diabetic macular edema (DME). This approval was partially based on 2 phase 3 studies, which also showed the potential to extend the time between treatments. Source: AAO
This week in the news, disparities in ophthalmic care between North American Native and White populations remain, migraine sufferers have a high risk of neovascular AMD, and thinner RNFL and GCL thickness may be a biomarker for early cognitive decline. Source: AAO
Liposomal ozonized oil plus hypromellose is a potential new option beyond povidine iodine to reduce bacterial flora load and the potential risk for endophthalmitis in cataract surgery. Source: AAO
Patients with diabetic macular edema (DME) who stopped anti-VEGF treatment for several months recovered vision and anatomic outcomes when treatment was resumed. Source: AAO
According to the World Heart Federation (WHF), no amount of alcohol consumption is safe, and there is no evidence confirming any benefits of alcohol. Source: AAO
The authors investigated breakthrough SARS-CoV-2 infections in health care workers by performing extensive evaluations of those who were symptomatic or had known infection exposure. Source: AAO
This week, a new video game aids in AMD detection, thinner RNFL thickness is seen in patients with both diabetes and hypertension, and safer options for conducting in-person IOP measurements are reviewed. Source: AAO
A review of cases from a single practice in the United States was conducted to determine the incidence of divergence insufficiency (DI) esotropia over a 41-year period. Source: AAO
Investigators compared telemedicine utilization among pediatric ophthalmologists in the United States at the beginning of the COVID-19 pandemic and several months into the pandemic. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »